Commercial newswire·US·
Traferox Technologies Inc. Receives FDA Clearance for the X°Port Heart Preservation System
Traferox Technologies Inc announces FDA-clearance of the X°Port Heart Preservation System
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Edge Marketing Earns First Place Honors in New York Law Journal Best of 2026 Survey
- Fast-Food Worker Turns TikTok Fame Into Viral Handbag Empire With BERRY-T Purses
- Airia Named Finalist in Four Categories in the 2026 AI Awards
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →Shared via PPN World — real-time press release intelligence.